Tandem Diabetes (TNDM) Tops Q4 EPS by 11c, Offers FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil prices steady as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Tandem Diabetes Care Reports Fourth Quarter and Full Year 2015 Financial Results
February 24, 2016 4:05 PM ESTSAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care®, Inc. (NASDAQ: TNDM), a medical device company and manufacturer of the t:slim®, t:flex® and t:slim G4 Insulin Pumps, today reported its financial results for the quarter and year ended December 31, 2015.
In comparing the fourth quarter of 2015 to the same period of 2014:
Sales grew 63 percent to $29.1 million from $17.9 million Pump shipments grew 59 percent to 6,234 pumps from 3,929 pumps Operating margin improved to negative 39 percent from negative 98 percentIn comparing the year ended December 31, 2015 to the same... More
